小细胞肺癌合并抗利尿激素分泌异常综合征的研究进展

恶性肿瘤可能合并抗利尿激素分泌异常综合征,其中以小细胞肺癌(small cell lung cancer,SCLC)最为多见.抗利尿激素分泌异常综合征(syndrome of inappropriate secretion of antidiuretic hormone,SIADH)主要是由于肿瘤细胞的神经内分泌功能或某些化疗药物的作用所致,具体表现为低钠血症,治疗方案主要包括针对原发病的治疗及针对低钠血症的治疗.继发于SIADH的低钠血症会影响患者预后,缩短生存时间,是肿瘤不良预后的独立危险因素.因此,对肿瘤患者SIADH的早期诊断、监测、治疗可改善患者的预后.

Research progress on small cell lung cancer with syndrome of inappropriate secretion of antidiuretic hormone

Many malignant tumors, most commonly small cell lung cancer, merge with syndrome of inappropriate secretion of antidi-uretic hormone (SIADH). SIADH is caused by the neuroendocrine function of tumor cells or is a side effect of chemotherapeutics. As a chemotherapeutic side effect, SIADH presents as hyponatremia. Therapy for SIADH includes both treatment for primary diseases and hyponatremia. Given that SIADH-induced hyponatremia aggravates the prognosis and shortens the survival time of patients with malig-nant tumors, SIADH is an independent risk factor for prognosis. Therefore, the early diagnosis, monitoring, and treatment of SIADH will improve the prognosis of patients with malignant tumors.